Human Health and Potential (HHP)

Researchers develop machine learning models for accurately diagnosing an inflammatory skin condition.

A new diagnostic innovation powered by artificial intelligence could empower surgeons to make more accurate and effective clinical decisions for colon cancer patients.

A new computational tool gives scientists a 3D view of the gene expression landscape in tissues to better track disease progression and design targeted drugs.

Advanced biosensors integrated into dressings capture molecular information to monitor whether wounds are healing.

Molecular simulations uncover a new druggable pocket in SARS-CoV-2’s spike protein which could hold the key to blocking COVID-19 infections.

A*STAR scientists decipher how a stem cell-based treatment stops the uncontrolled inflammation associated with severe COVID-19 cases.

Using a new genome analysis technology, A*STAR scientists discover never-before-seen immune responses in tuberculosis infections.

A new polymer gel may offer a drug-free solution to preventing retinal scarring after eye surgery.

Scientists discover a potential therapeutic target to tackle a dangerous drug-resistant yeast strain.

A protein called Agrin naturally produced in the skin could soon be the active ingredient in a treatment to boost skin repair in non-healing wounds.

More evidence emerges that fatty foods change skin composition, creating the perfect conditions for acne flare-ups.

Multidisciplinary efforts across A*STAR are paving the way toward Singapore’s precision medicine vision.